Navigation Links
AstraZeneca and Nektar Sign Worldwide Agreement for Nektar Drug Development Programmes -- NKTR-118 and NKTR-119 -- to Address Opioid-Induced Constipation
Date:9/21/2009

+44 20 7304 5130 (24 hours) Sarah Lindgreen +44 20 7304 5033 (24 hours) Emily Denney +1 302 885 3451 AZ Investor Enquiries UK: Jonathan Hunt +44 207 304 5087 mob: +44 7775 704032 Karl Hard +44 207 304 5322 mob: +44 7789 654364 AZ Investor Enquiries US: Ed Seage +1 302 886 4065 mob: +1 302 373 1361 Jorgen Winroth +1 212 579 0506 mob: +1 917 612 4043 (1.) Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract. 2007;61(7):1181-1187


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
2. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
3. AstraZeneca and Banner Alzheimers Institute Collaborate to Evaluate New Tool Targeting Alzheimers Disease
4. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
5. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
6. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
8. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
9. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
10. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
11. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... able to charge their cell phones and other person... discovery made by UC San Diego engineers could le...ould do just this. , In recent research, publis...u, a professor in the UCSD Department of Mechanica...tudent Mark Hoefer, have found that artificially i...
(Date:11/19/2009)... Md., Nov. 19 Spherix In...chnology for diabetes therapy, and a provider of t...d, supplement, biotechnology and pharmaceutical co...reported $6.3 million registered direct placement ...its common stock and warrants to purchase up to 1,...
(Date:11/19/2009)...ny, November 19 MONITORING FORCE G...h, 2009 Flibanserin in the,indication treatment-re...disease for orphan drug status designation with th...ed dyskinesia is a complication of the mainstay,tr...en to some of those,affected, since it may be disa...
(Date:11/19/2009)...d is honored by latest award for revolutionary hea...RWEB) November 16, 2009 -- Popular Science Magazin...ing aid from InSound Medical a winner of its covet...tegory.    Chosen from thousan...n the hearing canal for up to four months while pr...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...ire-FirstCall/ - AEterna Zentaris Inc.,(TSX: AEZ; ...focused on,endocrine therapy and oncology, will an... live webcast presentation and conference call hos...d J. Mazzo, Ph.D., the outcome,of management,s rev...ons,along with key elements of the new strategic p...
...e-FirstCall/ - Nventa,Biopharmaceuticals Corporati..., the Company,s President and Chief Executive Offi...nces: BioContact Quebec 2007 (Quebec, Canada)... Mr. McKee is scheduled to present on Thursday, ... Salle Laval Room at the Fairmont Le Chateau ...
...orforhire.com, the,fastest source for hiring indep...n faster. The company has added a mobile portal, e... immediately to work requests via,PDA or cell phon...cott Freedman, president of monitorforhire.com say...esponse times, enabling sponsors to staff,their tr...
Other Biology Technology:AEterna Zentaris Announces Outcome of Management's Strategic Review 2AEterna Zentaris Announces Outcome of Management's Strategic Review 3AEterna Zentaris Announces Outcome of Management's Strategic Review 4Nventa's CEO to present at two upcoming investor conferences 2
(Date:11/22/2009)...tists at the Brain Research Centre, a partnership ...edicine and Vancouver Coastal Health Research Inst...chanism by which brain cells die following a strok...ge. The results of the study were recently publish...roke, many brain cells continue to die even after ...
(Date:11/20/2009)... highly precise measurements of plasma lipoprotein...onance spectroscopy (NMR), researchers led by Dani...vard Medical School in Boston, MA, the Framingham ...rtium in Stockholm, Sweden and Oxford, England per...le genome among 17,296 women of European ancestry ...
(Date:11/20/2009)... Grafton, Mass., November 19, 2009 The estimated ...try may be at risk of developing respiratory sympt...ing to a questionnaire study undertaken earlier th...mings School of Veterinary Medicine. , The study...orkersfound that 50 percent of individuals working...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 1Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 2Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 3Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 4Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 1Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 2Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 3Entomological Society of America names 2009 Fellows 9734 1
...infectionA single molecular anchor that allows bac...y to treating many types of bacterial meningitis, ...l of Medicine study has found. , By blocking the ...ble to find a way to stave off the most common ser... major cause of childhood death and disability. Th...
...been used to track the source of illegal drugs, ex... agents may have some new uses: detecting rapidly ...sorders. , The method, known as "stable isotope r...stance was produced by "weighing" various forms or...the ratio of rare oxygen-18 to common oxygen-16. ...
...pkins Institute of Cell Engineering, a Johns Hopki...cal link between the health of stem cells and the ...osome ends, or telomeres, are repetitive stretches...way as plastic tips on shoelaces prevent the fabri...mosome ends get a little shorter, and eventually t...
Other Biology News:Researchers identify molecular anchor that allows bacterial invasion of central nervous system 2Researchers identify molecular anchor that allows bacterial invasion of central nervous system 3War on terror meets war on cancer 2War on terror meets war on cancer 3War on terror meets war on cancer 4War on terror meets war on cancer 5War on terror meets war on cancer 6A little telomerase isn't enough 2A little telomerase isn't enough 3A little telomerase isn't enough 4
HTP Zero Blunt TOPO PCR Cloning Kit for Sequencing MultiShot E. coli from Invitrogen
HISTOMOUNT SOLUTION from Invitrogen
Scaffold Software from Proteome Software Inc.
...tide derived from the N-terminal region of the hum... Specificity: Specific for the human occludin pro...2 cell lysates). Reactivity with rat mouse dog an...lotting Immunohistochemistry ImmunofluorescenceSto...
Biology Products: